New pain pump after back surgery could cut opioid use
NCT ID NCT00825422
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a continuous drip of numbing medicine into the surgical wound for two days after back fusion surgery could reduce pain and speed recovery better than a placebo. Fifty adults having lumbar fusion for degenerative spine disease took part. The goal was to improve pain control, reduce opioid side effects, and help patients get back on their feet faster.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEGENERATIVE LUMBAR SPINE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital
Bordeaux, 33076, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common cough drug dampen pain sensitivity?
- New tool aims to predict failed back surgery before it happens
- New nerve block technique aims to cut opioid use after back surgery
- Can a pinch of naloxone stop opioids from making pain worse?
- Spine surgeons test new CT technique to catch hidden instability during surgery
- Scientists test reliability of pain measures in capsaicin model